WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeStocks › PHAT

Which hedge funds own PHAT? PHATHOM PHARMACEUTICALS INC, Q2 2026 13F holders

Open on the interactive board

9 of the hedge funds tracked by WhaleCreep disclosed a position in PHAT (PHATHOM PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $66.8m in total. The largest holder by portfolio weight is Avidity Partners at 0.3% of its book. 1 manager opened a new position this quarter: Point72 Asset Management LP. 1 exited: Tudor Investment.

9tracked managers holding
1opened this quarter
1exited this quarter

Which hedge funds hold PHAT? Current holders by portfolio weight

ManagerAs ofWeight of bookValueSharesΔ sharesAction
Avidity PartnersQ2 2026 0.3%$2.2m200,000 -20% reduced
Millennium ManagementQ2 2026 0.0%$36.6m3,375,834 -16% reduced
Point72 Asset Management LPQ2 2026 0.0%$11.1m1,022,193 new
Woodline PartnersQ2 2026 0.0%$4.0m369,052 0% held
Marshall WaceQ2 2026 0.0%$7.2m666,090 -23% reduced
Renaissance Technologies LLCQ2 2026 0.0%$2.5m226,400 -26% reduced
Brevan Howard Capital ManagementQ2 2026 0.0%$158.4k14,599 -85% reduced
Citadel AdvisorsQ2 2026 0.0%$2.0m184,901 -52% reduced
D. E. Shaw & CoQ2 2026 0.0%$1.0m95,660 -28% reduced

Exited since the previous quarter

ManagerPrior weightPrior value
Tudor Investment0.0%$424.7k

How has hedge fund ownership of PHAT changed?

QuarterManagers holdingCombined value
Q2 20269$66.8m
Q1 20269$71.7m
Q4 20254$17.0m
Q3 20254$13.3m
Q2 20253$17.8m
Q1 20252$9.7m
Q4 20243$19.7m
Q3 20245$90.1m
Q2 20243$26.0m
Q1 20243$25.7m
Q4 20234$27.2m
Q3 20233$25.3m
Q2 20234$38.6m
Q1 20232$14.7m
Q4 20221$21.3m
Q3 20221$21.1m

Counts every tracked manager that disclosed PHAT in that quarter's filing, including managers that have since stopped filing.